###begin article-title 0
A New Inhibitor of Apoptosis from Vaccinia Virus and Eukaryotes
###end article-title 0
###begin p 1
###xml 44 58 <span type="species:ncbi:10245">vaccinia virus</span>
###xml 60 74 <span type="species:ncbi:28873">camelpox virus</span>
###xml 291 296 <span type="species:ncbi:9606">human</span>
###xml 338 343 <span type="species:ncbi:9606">human</span>
###xml 668 682 <span type="species:ncbi:10245">vaccinia virus</span>
###xml 767 773 <span type="species:ncbi:10090">murine</span>
A new apoptosis inhibitor is described from vaccinia virus, camelpox virus, and eukaryotic cells. The inhibitor is a hydrophobic, multiple transmembrane protein that is resident in the Golgi and is named GAAP (Golgi anti-apoptotic protein). Stable expression of both viral GAAP (v-GAAP) and human GAAP (h-GAAP), which is expressed in all human tissues tested, inhibited apoptosis induced by intrinsic and extrinsic apoptotic stimuli. Conversely, knockout of h-GAAP by siRNA induced cell death by apoptosis. v-GAAP and h-GAAP display overlapping functions as shown by the ability of v-GAAP to complement for the loss of h-GAAP. Lastly, deletion of the v-GAAP gene from vaccinia virus did not affect virus replication in cell culture, but affected virus virulence in a murine infection model. This study identifies a new regulator of cell death that is highly conserved in evolution from plants to insects, amphibians, mammals, and poxviruses.
###end p 1
###begin title 2
Author Summary
###end title 2
###begin title 3

###end title 3
###begin p 4
###xml 325 339 <span type="species:ncbi:10245">vaccinia virus</span>
###xml 344 358 <span type="species:ncbi:28873">camelpox virus</span>
###xml 413 418 <span type="species:ncbi:9606">human</span>
###xml 593 598 <span type="species:ncbi:9606">human</span>
###xml 899 904 <span type="species:ncbi:9606">human</span>
###xml 1043 1057 <span type="species:ncbi:10245">vaccinia virus</span>
Apoptosis is a conserved and strictly regulated process of cell suicide that, among other things, can remove virus-infected cells. In turn, many viruses, including poxviruses, have evolved strategies to block apoptosis to keep cells alive until virus replication is completed. Here, a novel viral anti-apoptotic protein from vaccinia virus and camelpox virus, viral Golgi anti-apoptotic protein (v-GAAP), and its human counterpart, h-GAAP, are described. Evolutionarily, GAAPs are extremely well conserved with closely related proteins in plants, insects, amphibia, and mammals, the viral and human counterparts sharing a striking 73% sequence identity. GAAPs are resident in the Golgi and inhibit apoptosis induced by a wide range of apoptotic stimuli. Knockout of h-GAAP, which is expressed in every tissue tested, induced cell death by apoptosis. The close relationship between the viral and the human proteins was confirmed in that v-GAAP could complement for the loss of h-GAAP and promote cell survival. Deletion of the v-GAAP gene from vaccinia virus affected virus virulence. Thus, this study identifies a new regulator of cell death that is highly conserved in evolution and has been hijacked by poxviruses. These data support a role for the Golgi complex in sensing pro-apoptotic stimuli.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 329 330 329 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030017-b001">1</xref>
###xml 578 579 578 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030017-b002">2</xref>
###xml 826 827 826 827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030017-b003">3</xref>
###xml 828 829 828 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030017-b005">5</xref>
Cell death is the result of either necrosis or apoptosis. Necrosis is the outcome of severe and acute injury, whereas apoptosis is an evolutionarily conserved, strictly regulated, energy-dependent process of cell suicide responsible for the ordered removal of superfluous, aged, or damaged cells, including virus-infected cells [1]. The signals that trigger apoptosis can be either extrinsic, and are sensed by death receptors at the cell surface, or intrinsic following perturbation of intracellular homeostasis, and are sensed by cellular organelles that initiate cell death [2]. The mitochondrion is the best known organelle regulating apoptosis, but the endoplasmic reticulum (ER), lysosomes, nucleus, and Golgi apparatus can all transmit stress signals to mitochondria, and thus contribute to the induction of apoptosis [3-5].
###end p 6
###begin p 7
###xml 78 79 78 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030017-b006">6</xref>
###xml 86 99 86 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Orthopoxvirus</italic>
###xml 175 176 175 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030017-b007">7</xref>
###xml 204 205 204 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">,</italic>
###xml 374 375 374 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030017-b008">8</xref>
###xml 478 479 478 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030017-b009">9</xref>
###xml 824 826 824 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030017-b010">10</xref>
###xml 1076 1078 1076 1078 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030017-b011">11</xref>
###xml 191 204 <span type="species:ncbi:10255">variola virus</span>
###xml 219 227 <span type="species:ncbi:10255">smallpox</span>
###xml 229 243 <span type="species:ncbi:10245">vaccinia virus</span>
###xml 245 249 <span type="species:ncbi:10245">VACV</span>
###xml 282 290 <span type="species:ncbi:10255">smallpox</span>
###xml 296 310 <span type="species:ncbi:28873">camelpox virus</span>
###xml 312 316 <span type="species:ncbi:28873">CMLV</span>
###xml 359 372 <span type="species:ncbi:10255">variola virus</span>
Poxviruses are a family of large DNA viruses that replicate in the cytoplasm [6]. The Orthopoxvirus genus is the most extensively characterised genus of the Chordopoxvirinae [7] and includes variola virus, the cause of smallpox, vaccinia virus (VACV), the vaccine used to eradicate smallpox, and camelpox virus (CMLV), which is closely related genetically to variola virus [8]. The orthopoxviruses have genomes of approximately 200 kilobase pairs and encode about 200 proteins [9]. Proteins encoded in the terminal regions of the genome are mostly non-essential for virus replication but affect virus virulence, host range, or the host responses to infection. This group of proteins is numerous and includes those that are secreted from the infected cell and bind complement factors, interferons, cytokines, and chemokines [10]. Alternatively, poxvirus immunomodulatory proteins may be intracellular and interfere with signalling pathways regulating cellular gene expression or apoptosis. Several poxvirus proteins that inhibit apoptosis have been described (for review, see [11]).
###end p 7
###begin p 8
###xml 285 291 <span type="species:ncbi:10090">murine</span>
###xml 392 397 <span type="species:ncbi:9606">human</span>
###xml 440 445 <span type="species:ncbi:9606">human</span>
This study describes the identification and characterisation of a new poxvirus anti-apoptotic protein that is located in the Golgi and is called viral Golgi anti-apoptotic protein (v-GAAP). v-GAAP is non-essential for virus replication in cell culture but affects virus virulence in a murine model of infection. Strikingly, v-GAAP shows very high conservation with a hitherto uncharacterised human protein (h-GAAP) that is expressed in all human tissues tested, is essential for cell viability, is anti-apoptotic, and is conserved in plants, insects, amphibia, and mammals.
###end p 8
###begin title 9
Results
###end title 9
###begin title 10
Identification of GAAPs
###end title 10
###begin p 11
###xml 10 12 10 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6L</italic>
###xml 95 96 95 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030017-b008">8</xref>
###xml 484 498 484 498 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Xenopus laevis</named-content>
###xml 628 648 628 648 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Arabidopsis thaliana</named-content>
###xml 668 691 668 691 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Drosophila melanogaster</named-content>
###xml 708 716 708 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030017-g001">Figure 1</xref>
###xml 0 4 <span type="species:ncbi:28873">CMLV</span>
###xml 153 158 <span type="species:ncbi:9606">human</span>
###xml 396 405 <span type="species:ncbi:9600|species:ncbi:9601">orangutan</span>
###xml 422 425 <span type="species:ncbi:9615">dog</span>
###xml 442 447 <span type="species:ncbi:10090">mouse</span>
###xml 464 467 <span type="species:ncbi:10116">rat</span>
###xml 484 498 <span type="species:ncbi:8355">Xenopus laevis</span>
###xml 519 528 <span type="species:ncbi:7955">zebrafish</span>
###xml 628 648 <span type="species:ncbi:3702">Arabidopsis thaliana</span>
###xml 668 691 <span type="species:ncbi:7227">Drosophila melanogaster</span>
CMLV gene 6L encodes a 237-amino acid (aa) protein with a putative molecular mass of 26.5 kDa [8]. Database searches revealed a striking similarity to a human protein (73% identity, h-GAAP) of unknown function that is present in public databases under different names (e.g., z-protein, CGI-119, and S1R protein). BLAST searches with h-GAAP identified closely related, uncharacterised proteins in orangutan (96% identity), dog (89% identity), mouse (84% identity), rat (84% identity), Xenopus laevis (69% identity), and zebrafish (65% identity). In addition, there are related proteins of similar size predicted to be encoded by Arabidopsis thaliana (38% identity) and Drosophila melanogaster (34% identity) (Figure 1A).
###end p 11
###begin p 12
###xml 315 323 315 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030017-g001">Figure 1</xref>
###xml 366 368 366 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030017-b012">12</xref>
###xml 511 513 511 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030017-b013">13</xref>
###xml 678 680 678 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030017-b014">14</xref>
###xml 681 683 681 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030017-b015">15</xref>
###xml 821 823 821 823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030017-b016">16</xref>
###xml 383 388 <span type="species:ncbi:9606">human</span>
Comparison of the sequence of all putative GAAPs showed that, evolutionarily, GAAPs are extremely well conserved in length (235-239 aa) and sequence identity. The close relationship between GAAPs is supported further by their conserved hydrophobicity profile, which predicted a six or seven transmembrane topology (Figure 1B and unpublished data). The PFAM program [12] assigned the human and viral GAAPs to the protein family UPF0005, whose members are predicted to contain six or seven transmembrane domains [13]. Two characterised UPF0005 family members show similarity to GAAPs. Bax inhibitor-1, which protects cells against ER stress, shares 28% identity (45% similarity) [14,15], and lifeguard, which protects cells from Fas-mediated cell death in the brain and other tissues, shares 34% identity (51% similarity) [16].
###end p 12
###begin p 13
Collectively, these data suggest that GAAPs have an important and evolutionarily conserved function, possibly in regulating apoptosis.
###end p 13
###begin title 14
v-GAAP Is an Early Protein That Is Non-Essential for Virus Replication and Localises to the Golgi
###end title 14
###begin p 15
###xml 381 386 381 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">110L,</italic>
###xml 414 417 414 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D8L</italic>
###xml 419 420 419 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030017-b008">8</xref>
###xml 421 423 421 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030017-b017">17</xref>
###xml 502 510 502 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030017-g002">Figure 2</xref>
###xml 79 83 <span type="species:ncbi:28873">CMLV</span>
###xml 366 370 <span type="species:ncbi:28873">CMLV</span>
###xml 404 408 <span type="species:ncbi:10245">VACV</span>
To examine the kinetics of v-GAAP protein expression, cells were infected with CMLV in the presence or absence of cytosine arabinoside (AraC), an inhibitor of DNA replication and late gene expression. Reverse transcription (RT)-PCR detected v-GAAP messenger RNA (mRNA) from 2 h post infection (p.i.) onward and at 22 h p.i. in the presence of AraC. In contrast, the CMLV late gene 110L, a counterpart of VACV gene D8L [8,17], was only transcribed late during infection and not in the presence of AraC (Figure 2A, left panel).
###end p 15
###begin p 16
###xml 363 366 363 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6L,</italic>
###xml 401 403 401 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030017-b018">18</xref>
###xml 502 504 502 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6L</italic>
###xml 572 574 572 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6L</italic>
###xml 94 98 <span type="species:ncbi:28873">CMLV</span>
###xml 223 227 <span type="species:ncbi:28873">CMLV</span>
###xml 353 357 <span type="species:ncbi:28873">CMLV</span>
###xml 388 392 <span type="species:ncbi:10245">VACV</span>
###xml 442 446 <span type="species:ncbi:10245">VACV</span>
There is no established small animal model for studying the contribution of specific genes to CMLV pathogenesis, so to investigate the role of v-GAAP in virus virulence, we searched other orthopoxviruses for orthologues of CMLV 6L. Bioinformatic analysis of poxvirus genomes () showed that the majority of orthopoxviruses do not encode an orthologue of CMLV gene 6L, but an exception was VACV Lister [18]. PCR amplification of genomic DNA of VACV strains Lister, USSR, and Evans using primers for CMVL 6L yielded a 714-base pair (bp) fragment, the same length as the CMVL 6L gene (unpublished data). DNA sequencing confirmed that these viruses encoded proteins of 237 aa with 94%-95% identity with CMVL 6L.
###end p 16
###begin p 17
###xml 117 123 117 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v-GAAP</italic>
###xml 764 772 760 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030017-g002">Figure 2</xref>
###xml 884 886 880 882 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030017-b019">19</xref>
###xml 964 970 960 966 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v-GAAP</italic>
###xml 49 53 <span type="species:ncbi:10245">VACV</span>
###xml 802 806 <span type="species:ncbi:10245">VACV</span>
###xml 950 954 <span type="species:ncbi:28873">CMLV</span>
###xml 959 963 <span type="species:ncbi:10245">VACV</span>
To study the role of the viral protein, a set of VACV strain Evans viruses (v-GAAP WT) were constructed in which the v-GAAP gene was deleted (v-DeltaGAAP) and re-inserted (v-GAAP Rev) into the deletion mutant. We also constructed a virus in which v-GAAP contained a C-terminal hemagglutinin (HA) tag (vGAAP RevHA). PCR and Southern blot analysis confirmed that the genomic structures of all viruses were as predicted. Comparisons of the growth of the recombinant viruses in cell culture showed there were no differences in plaque phenotype or yield of intracellular virus (unpublished data). Immunoblotting of extracts from v-GAAP RevHA-infected cells with anti-HA antibody (Ab) detected v-GAAP as a 23-kDa protein that was present early and throughout infection (Figure 2A, right panel). In contrast, VACV protein A36 was expressed only late during infection as reported previously [19]. These analyses showed that the kinetics of expression of the CMLV and VACV v-GAAP genes were indistinguishable.
###end p 17
###begin p 18
###xml 266 274 262 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030017-g002">Figure 2</xref>
###xml 487 495 483 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030017-g002">Figure 2</xref>
###xml 794 802 782 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030017-g002">Figure 2</xref>
To study the intracellular location of GAAPs, an Ab was raised against a GAAP peptide, SSIEDDFNYGSSV (h-GAAP aa 11-23 and v-GAAP aa 10-22). Cells were infected with v-GAAP WT, v-DeltaGAAP, and v-GAAP Rev and fixed for immunofluorescence analysis 3, 6, or 24 h p.i. (Figure 2B, left subpanels; unpublished data). v-GAAP co-localised with the Golgi marker GM130 at each time point. Note that under these conditions, endogenous h-GAAP was not detected due to its lower level of expression (Figure 2B, middle left subpanel). In addition, very late post-infection (24 h) v-GAAP was also detected in the nuclear membrane and the ER (unpublished data). The alpha-GAAP antibody also recognised v-GAAP as a 23-kDa protein in extracts of cells infected with v-GAAP WT and v-GAAP Rev but not v-DeltaGAAP (Figure 2B, right panel).
###end p 18
###begin p 19
###xml 40 44 <span type="species:ncbi:10245">VACV</span>
###xml 103 107 <span type="species:ncbi:10245">VACV</span>
Therefore, v-GAAP is expressed early in VACV infection, localises to the Golgi, and is dispensable for VACV growth in cell culture.
###end p 19
###begin title 20
h-GAAP Is Expressed in All Tissues Tested and Localises to the Golgi
###end title 20
###begin p 21
###xml 51 59 51 59 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030017-g001">Figure 1</xref>
###xml 348 356 348 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030017-g002">Figure 2</xref>
###xml 561 569 557 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030017-g002">Figure 2</xref>
###xml 119 124 <span type="species:ncbi:9606">human</span>
###xml 166 171 <span type="species:ncbi:9606">human</span>
###xml 325 330 <span type="species:ncbi:9606">human</span>
###xml 635 640 <span type="species:ncbi:9606">human</span>
GAAPs are extremely well conserved evolutionarily (Figure 1). To investigate whether h-GAAP was expressed in different human tissue, complementary DNA (cDNA) from 16 human tissues obtained from multiple disease-free individuals was used for PCR analysis of h-GAAP gene expression. This showed that h-GAAP is expressed in all human tissue examined (Figure 2C). Next, the alpha-GAAP Ab was used to study the location of h-GAAP by immunofluorescence; this demonstrated that endogenous h-GAAP co-localised with the Golgi marker GM130 in HeLa, SiHa, and BGMK cells (Figure 2D and unpublished data). Therefore, h-GAAP is widely expressed in human tissues and, like v-GAAP, is a Golgi protein.
###end p 21
###begin title 22
Expression of GAAPs
###end title 22
###begin p 23
###xml 148 156 148 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030017-g003">Figure 3</xref>
###xml 162 163 162 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030017-g003">3</xref>
###xml 208 216 208 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030017-g003">Figure 3</xref>
###xml 391 399 391 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030017-g003">Figure 3</xref>
###xml 514 522 514 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030017-g002">Figure 2</xref>
###xml 766 774 766 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030017-g003">Figure 3</xref>
###xml 845 853 845 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030017-g003">Figure 3</xref>
###xml 1013 1016 1013 1016 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 1020 1025 1020 1025 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 1142 1150 1142 1150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030017-g003">Figure 3</xref>
###xml 1261 1269 1261 1269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030017-g003">Figure 3</xref>
###xml 1488 1496 1488 1496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030017-g003">Figure 3</xref>
###xml 1568 1576 1568 1576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030017-g003">Figure 3</xref>
###xml 1793 1802 1793 1802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat-0030017-sg001">Figure S1</xref>
###xml 498 502 <span type="species:ncbi:10245">VACV</span>
###xml 1627 1653 <span type="species:ncbi:11276">vesicular stomatitis virus</span>
To investigate the function of GAAPs, we expressed h-GAAP or v-GAAP bearing a C-terminal HA tag in stable cell lines (U2OS-v-GAAP and U2OS-h-GAAP) (Figure 3A and 3B) and in cells transiently by transfection (Figure 3C). In U2OS cells stably expressing h-GAAP or v-GAAP, the expression levels varied among individual cells, but, in all cases, GAAPs co-localised with the Golgi markers GM130 (Figure 3A) and giantin (unpublished data). This subcellular distribution was the same as for v-GAAP during VACV infection (Figure 2). In cells with higher expression levels, h-GAAP and v-GAAP were also seen in a reticular network characteristic of the ER (co-staining with protein disulfide isomerase, unpublished data). A similar distribution was seen in transfected cells (Figure 3C): early after transfection, viral GAAPs localized to only the Golgi (Figure 3C), but later, as their concentration increased, they were also present in the ER (unpublished data). To examine if GAAP expression was polarised to either the cis or trans Golgi cisternae, U2OS-v-GAAP and U2OS-h-GAAP cells were analysed by immunoelectron microscopy using protein-A gold (Figure 3B) or immunocytochemistry (unpublished data). v-GAAP was expressed throughout the stacks of the Golgi complex (Figure 3B, upper left panel), and similar results were obtained for h-GAAP (unpublished data). In U2OS-v-GAAP, and to a lesser extent in U2OS-h-GAAP cells, the Golgi complex appeared more dispersed than in parental U2OS cells (Figure 3A), but electron microscopy showed retention of Golgi stack morphology (Figure 3B). Moreover, transfection of a plasmid expressing vesicular stomatitis virus glycoprotein fused to green fluorescent protein (VSV-GFP) into these cells showed that protein trafficking to the cell surface was normal (Figure S1).
###end p 23
###begin p 24
###xml 16 21 <span type="species:ncbi:9606">human</span>
Therefore, both human and viral GAAPs are distributed throughout the Golgi stacks, and when they are overexpressed, glycoprotein trafficking to the plasma membrane is normal.
###end p 24
###begin title 25
h-GAAP Is Necessary for Cell Survival
###end title 25
###begin p 26
###xml 291 299 291 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030017-g004">Figure 4</xref>
###xml 435 443 435 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030017-g004">Figure 4</xref>
###xml 871 880 871 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030017-g004">Figures 4</xref>
###xml 886 888 886 888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat-0030017-sg002">S2</xref>
###xml 1087 1095 1087 1095 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030017-g004">Figure 4</xref>
###xml 1296 1304 1296 1304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030017-g004">Figure 4</xref>
###xml 1469 1477 1469 1477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030017-g004">Figure 4</xref>
To study h-GAAP function, three small interfering RNAs (GAAP siRNAs 1-3) were designed to down-regulate h-GAAP expression. RT-PCR showed that GAAP siRNAs 1 and 3 down-regulated h-GAAP mRNA substantially by 36 h post transfection, whereas GAAP siRNA2 and a control siRNA against GFP did not (Figure 4A). Strikingly, transfection of HeLa cells with GAAP siRNAs 1 and 3, but not GAAP siRNA2, induced cell death by 56 h post transfection (Figure 4B). Next, we measured the mitochondrial membrane potential using the membrane potential-sensitive dye tetramethylrhodamine ethyl ester (TMRE) 56 h after transfection of HeLa cells with GAAP siRNAs 1-3. Consistent with cell morphology changes, HeLa cells transfected with GAAP siRNAs 1 and 3 showed a decreased uptake of the TMRE compared with that of mock-transfected cells and cells transfected with GAAP siRNA2 and GFP-siRNA (Figures 4C and S2). In addition, immunoblotting showed cleavage of poly (adenosine diphosphate-ribose) polymerase (PARP) in HeLa cells transfected with h-GAAP siRNA1, but not in mock- or GFP-siRNA-transfected cells (Figure 4D). Immunofluorescence using U2OS-h-GAAP cells confirmed that h-GAAP protein expression was reduced to background by 36 h after transfection with GAAP siRNAs 1 and 3, but not with siRNA2 or GFP-siRNA (Figure 4E). Immunoblotting demonstrated that h-GAAP protein expression was undetectable 56 h after transfection with GAAP siRNAs 1 and 3, but not with siRNA2 and GFP-siRNA (Figure 4F). These data indicate that h-GAAP is necessary for cell survival.
###end p 26
###begin title 27
GAAPs Inhibit Apoptosis Triggered by the Intrinsic Pathway
###end title 27
###begin p 28
###xml 412 413 412 413 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 425 427 425 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030017-b020">20</xref>
###xml 428 430 428 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030017-b024">24</xref>
###xml 656 664 656 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030017-g005">Figure 5</xref>
###xml 1026 1034 1026 1034 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030017-g005">Figure 5</xref>
###xml 1155 1163 1155 1163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030017-g005">Figure 5</xref>
###xml 588 592 <span type="species:ncbi:28873">CMLV</span>
###xml 596 600 <span type="species:ncbi:10245">VACV</span>
###xml 968 972 <span type="species:ncbi:28873">CMLV</span>
###xml 976 980 <span type="species:ncbi:10245">VACV</span>
The similarity of GAAPs to anti-apoptotic proteins (lifeguard and Bax inhibitor-1) and the observation that knock down of h-GAAP expression induced apoptosis, suggest that GAAPs regulate apoptosis. Accordingly, we tested whether h-GAAP and v-GAAP affected the induction of apoptosis by five different pro-apoptotic stimuli that act through the intrinsic pathway (Bax, staurosporine, cisplatin, doxorubicin, and C2-ceramide) [20-24]. To test whether GAAPs modulate Bax-induced apoptosis, Saos-2 cells were transfected with an expression plasmid for Bax alone, or together with pCI-v-GAAP (CMLV or VACV Evans) or pCI-h-GAAP and the cell surface marker CD20. Figure 5A (left panel) shows representative DNA profiles of transfected (CD20-positive) cells 36 h post transfection. Quantification of sub-G1 cell populations (M1) showed that expression of Bax alone caused ~25% apoptosis among the transfected cell population, and this number was reduced by half when v-GAAPs (CMLV or VACV Evans) or h-GAAP were co-expressed with Bax (Figure 5A, right panel). Immunoblot analysis demonstrated that expression of GAAPs did not interfere with Bax expression levels (Figure 5B, right panel).
###end p 28
###begin p 29
###xml 225 233 224 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030017-g005">Figure 5</xref>
###xml 578 586 576 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030017-g005">Figure 5</xref>
Apoptosis was then induced using staurosporine, a broad-spectrum kinase inhibitor. Staurosporine (3 muM) induced apoptosis in only 28% and 46% U2OS-v-GAAP and U2OS-h-GAAP cells, respectively, when compared to U2OS-neo cells (Figure 5B). To assess whether h-GAAP could also suppress cell death induced via p53 activation, U2OS-neo, U2OS-v-GAAP, and U2OS-h-GAAP cells were treated with cisplatin or doxorubicin. Treatment of cells with cisplatin (10 mug/ml) resulted in apoptosis in 38% and 48% of U2OS-v-GAAP and U2OS-h-GAAP cells, respectively, when compared to U2OS-neo cells (Figure 5B). Similar results were obtained after doxorubicin treatment (unpublished data).
###end p 29
###begin p 30
###xml 166 167 166 167 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 367 375 366 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030017-g005">Figure 5</xref>
Thus, GAAPs inhibit apoptosis in response to Bax, staurosporine, cisplatin, and doxorubicin. However, the most striking anti-apoptotic activity of GAAPs was against C2-ceramide (10 muM). This treatment induced apoptosis in 35% of U2OS-neo cells, whereas apoptosis in U2OS v-GAAP and U2OS-h-GAAP cells was inhibited completely and remained similar to untreated cells (Figure 5D).
###end p 30
###begin title 31
GAAPs Regulate Cell Susceptibility to Apoptosis Triggered by the Extrinsic Pathway
###end title 31
###begin p 32
###xml 335 343 331 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030017-g006">Figure 6</xref>
###xml 584 585 576 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 806 814 794 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030017-g006">Figure 6</xref>
###xml 176 181 <span type="species:ncbi:9606">human</span>
###xml 199 204 <span type="species:ncbi:9606">human</span>
###xml 438 443 <span type="species:ncbi:9606">human</span>
To investigate whether h-GAAP and v-GAAP could inhibit apoptosis triggered via the extrinsic pathway, U2OS-neo, U2OS-v-GAAP, or U2OS-h-GAAP cells were treated with either anti-human Fas Ab (CH11) or human tumour necrosis factor (TNF)-alpha. Treatment with anti-Fas Ab and cycloheximide (CHX) caused apoptosis in 22% of U2OS-neo cells (Figure 6A) compared to 10% in U2OS-h-GAAP cells and 6% in U2OS-v-GAAP cells. Similarly, treatment with human TNF-alpha and CHX caused apoptosis in 19% of control cells, but only in 11% of U2OS-h-GAAP cells and 5% of U2OS-v-GAAP cells. Consistently (n = 3), compared to control cells treated with anti-Fas antibody or TNF-alpha (designated as 100%), apoptosis was reduced to 46.3% and 62.5% in U2OS h-GAAP cells and to 28.2% and 29.6% in U2-OS v-GAAP cells, respectively (Figure 6B).
###end p 32
###begin p 33
###xml 295 303 291 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030017-g006">Figure 6</xref>
###xml 422 430 418 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030017-g006">Figure 6</xref>
###xml 606 611 <span type="species:ncbi:9606">human</span>
To define the site of action of h-GAAP, we treated U2OS-neo and U2OS-h-GAAP cells with TNF-alpha and CHX and examined cleavage of caspase-8. There was no gross difference in proteolytic cleavage of caspase-8 into its active p43/p41 and p18 fragments between both cell lines after 2, 4, and 6 h (Figure 6C). In contrast, from 2 h onwards, cleavage of the PARP was reduced in U2OS-h-GAAP compared to that in U2OS-neo cells (Figure 6D). Similar results were obtained after Fas and CHX treatment (unpublished data) and when comparing U2OS-neo with U2OS-v-GAAP cells (unpublished data). Thus, overexpression of human and viral GAAPs provides partial protection against apoptosis triggered by the extrinsic pathway, and this inhibition takes place downstream of caspase-8 cleavage.
###end p 33
###begin title 34
v-GAAP Can Complement for Loss of h-GAAP
###end title 34
###begin p 35
###xml 657 665 657 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030017-g007">Figure 7</xref>
###xml 692 700 692 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030017-g004">Figure 4</xref>
###xml 810 818 810 818 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030017-g007">Figure 7</xref>
###xml 973 981 973 981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030017-g007">Figure 7</xref>
###xml 1077 1085 1077 1085 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030017-g004">Figure 4</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 145 150 <span type="species:ncbi:9606">human</span>
###xml 365 370 <span type="species:ncbi:9606">human</span>
Human and viral GAAP RNA sequences share 77% nucleotide identity, so the use of specific siRNAs enables differential degradation of viral and/or human mRNA. GAAP siRNA1 was designed to down-regulate h-GAAP and v-GAAP, whereas GAAP siRNAs 2 and 3 were specific for h-GAAP. Accordingly, we tested GAAP siRNAs 1-3 for their ability to down-regulate v-GAAP in the U2OS human cell line that we had engineered to stably express v-GAAP, U2OS-v-GAAP. Immunofluorescence analysis showed that 36 h post transfection, GAAP siRNA1 down-regulated h-GAAP and v-GAAP, whereas siRNAs 2 and 3 did not affect v-GAAP expression, and siRNA2 affected neither h-GAAP nor v-GAAP (Figure 7A). Just as in HeLa cells (Figure 4B), U2OS-h-GAAP cells transfected with h-GAAP siRNAs 1 and 3, but not siRNA2, died by 48 h post transfection (Figure 7B, lower panels). In contrast, U2OS-v-GAAP cells, in which endogenous h-GAAP was down-regulated but v-GAAP was still expressed (siRNA3), remained healthy (Figure 7B, upper panels). Consistent with the cell morphology and the result of HeLa cell transfection (Figure 4B), U2OS-h-GAAP cells transfected with GAAP siRNAs 1 and 3 and U2OS-v-GAAP transfected with GAAP siRNA1 showed reduced uptake of TMRE (unpublished data).
###end p 35
###begin p 36
Therefore, downregulation of h-GAAP causes cell death by apoptosis, and v-GAAP can complement for loss of h-GAAP to promote cell survival.
###end p 36
###begin title 37
v-GAAP Is a Virulence Factor
###end title 37
###begin p 38
###xml 96 98 96 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030017-b025">25</xref>
###xml 99 101 99 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030017-b026">26</xref>
###xml 143 144 143 144 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 329 331 325 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030017-b027">27</xref>
###xml 380 381 376 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 534 542 526 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030017-g008">Figure 8</xref>
###xml 599 600 591 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 621 622 611 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 711 719 697 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030017-g008">Figure 8</xref>
###xml 788 789 774 775 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 71 77 <span type="species:ncbi:10090">murine</span>
###xml 104 108 <span type="species:ncbi:10090">Mice</span>
###xml 454 458 <span type="species:ncbi:10090">mice</span>
###xml 772 776 <span type="species:ncbi:10090">mice</span>
###xml 814 818 <span type="species:ncbi:10090">mice</span>
###xml 891 895 <span type="species:ncbi:10090">mice</span>
The role of v-GAAP protein in virus virulence was investigated using a murine intranasal model [25,26]. Mice were infected intranasally with 107 plaque-forming units (pfu) of v-GAAP WT, v-DeltaGAAP, or v-GAAP Rev, and the weight change and signs of illness (ruffled fur, arched backs, reduced mobility, or evidence of pneumonia [27]) were assessed daily. In repeated experiments (n = 5), there was no significant difference in weight loss when comparing mice infected with v-DeltaGAAP to those infected with v-GAAP WT and v-GAAP Rev (Figure 8A). However, a significant increase in signs of illness (p </= 0.05, Student's t-test) was observed in v-DeltaGAAP compared to both control groups on days 5 and 8 p.i. (Figure 8B). Similar results were obtained after infection of mice with 3 x 106 pfu (unpublished data): mice infected with v-DeltaGAAP showed increased signs of illness compared to mice infected with v-GAAP WT and v-GAAP Rev.
###end p 38
###begin p 39
###xml 210 211 206 207 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 496 497 492 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 691 699 683 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030017-g008">Figure 8</xref>
###xml 702 703 694 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 724 725 714 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 778 780 768 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030017-b028">28</xref>
###xml 452 456 <span type="species:ncbi:10090">mice</span>
###xml 605 609 <span type="species:ncbi:10090">mice</span>
###xml 646 650 <span type="species:ncbi:10090">mice</span>
###xml 762 766 <span type="species:ncbi:10245">VACV</span>
To assess why infection with v-DeltaGAAP resulted in more severe signs of illness, the virus titres in lungs were determined at different times p.i. Each virus replicated well in lung tissue to reach titres >106 pfu/gm of tissue by 3 d p.i., and there were no statistically significant differences between virus titres of the different groups detected on this day or later (unpublished data). Next, the inflammatory infiltrate in the lungs of infected mice was examined. In repeated experiments (n = 3), at days 6 and 8 p.i., significantly more cells were recovered from bronchoalveolar lavages (BALs) of mice infected with v-DeltaGAAP than from mice infected with v-GAAP WT and v-GAAP Rev (Figure 8C; p </= 0.01, Student's t-test). As reported previously after VACV infection [28], there was a low level of cell recruitment to the lungs of infected animals early after infection, and this increased to a maximum at 10 d p.i. with v-GAAP WT and v-GAAP Rev, and at day 8 with v-DeltaGAAP (unpublished data).
###end p 39
###begin p 40
###xml 64 68 <span type="species:ncbi:10245">VACV</span>
###xml 86 92 <span type="species:ncbi:10090">murine</span>
These results show that loss of v-GAAP altered the virulence of VACV in an intranasal murine model of infection.
###end p 40
###begin title 41
Discussion
###end title 41
###begin p 42
###xml 61 65 <span type="species:ncbi:10245">VACV</span>
###xml 67 71 <span type="species:ncbi:28873">CMLV</span>
###xml 327 332 <span type="species:ncbi:9606">human</span>
###xml 405 409 <span type="species:ncbi:10245">VACV</span>
###xml 488 494 <span type="species:ncbi:10090">murine</span>
###xml 672 677 <span type="species:ncbi:9606">human</span>
###xml 767 772 <span type="species:ncbi:9606">human</span>
A new regulator of apoptosis is described that is encoded by VACV, CMLV, and many other eukaryotes. This protein is called Golgi-anti-apoptotic protein because of its function and subcellular location. Overexpression of h-GAAP or v-GAAP rendered cells resistant to induction of apoptosis, while knock down of expression of the human gene by siRNA caused cells to die by apoptosis. Deletion of v-GAAP from VACV did not affect virus replication in cell culture, but affected virulence in a murine model of infection. v-GAAP therefore represents a new virus-encoded apoptosis inhibitor. v-GAAP is remarkable in that it is very closely related to a previously uncharacterised human protein (h-GAAP) that is conserved in a wide range of eukaryotes, is expressed in all 16 human tissues tested, and is essential for cell viability.
###end p 42
###begin p 43
###xml 139 141 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030017-b010">10</xref>
###xml 142 144 142 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030017-b029">29</xref>
###xml 506 508 506 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030017-b011">11</xref>
###xml 0 4 <span type="species:ncbi:10245">VACV</span>
###xml 451 455 <span type="species:ncbi:10245">VACV</span>
VACV and other poxviruses express a wide range of proteins that interfere with aspects of the host response to infection (for reviews see [10,29]). These proteins may act inside or outside the cell, and most of them target the innate response to infection. Among the intracellular regulators of the innate response, a subset block the induction of apoptosis, so that virus replication can be completed before the cells dies. Apoptosis regulators from VACV and other poxviruses have been reviewed recently [11] and include proteins that inhibit caspase activity, or are present at the mitochondrial membrane. v-GAAP is another example of an intracellular apoptosis inhibitor, but it has three striking differences from the ones discovered previously.
###end p 43
###begin p 44
###xml 160 161 160 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030017-b005">5</xref>
###xml 162 164 162 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030017-b030">30</xref>
First, v-GAAP (and h-GAAP) is present in the Golgi, a compartment that until recently was not thought to have an important role in the regulation of apoptosis [5,30]. This observation supports recent evidence that the Golgi has a role in the regulation of apoptosis. Other poxvirus proteins that affect induction of apoptosis are located either at mitochondria or are in the cytosol.
###end p 44
###begin p 45
###xml 367 378 367 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arabidopsis</italic>
###xml 635 637 635 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030017-b031">31</xref>
###xml 1161 1163 1158 1160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030017-b032">32</xref>
###xml 1193 1195 1186 1188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030017-b033">33</xref>
###xml 1239 1241 1229 1231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030017-b034">34</xref>
###xml 44 49 <span type="species:ncbi:9606">human</span>
###xml 130 135 <span type="species:ncbi:9606">human</span>
###xml 357 362 <span type="species:ncbi:9606">human</span>
###xml 553 558 <span type="species:ncbi:9606">human</span>
###xml 719 724 <span type="species:ncbi:9606">human</span>
###xml 1248 1252 <span type="species:ncbi:10245">VACV</span>
###xml 1300 1305 <span type="species:ncbi:9606">human</span>
###xml 1520 1524 <span type="species:ncbi:10245">VACV</span>
Second, v-GAAP is very closely related to a human protein that shows remarkable conservation throughout eukaryotes. The virus and human protein have 73% aa identity, a similar hydropathy profile, and a very similar length. Moreover, the genomes of many eukaryotes (plants, insects, amphibia, and mammals) encode a closely related protein. For instance, the human and Arabidopsis GAAPs share 38% aa identity and differ in length by only 4 aa. Hitherto, the function of the protein we have called GAAP had not been determined in any species, although the human gene was one of several reported to be up-regulated in some breast tumours [31]. Data presented here provide the first characterisation to our knowledge of the human protein, and demonstrate that this protein is essential for cell viability and that cells die by apoptosis in its absence. In addition, it is shown that the viral protein can complement the essential function served by h-GAAP. Other immunoregulatory proteins from poxviruses either have no orthologues outside poxviruses or have a much lower amino acid identity with cellular counterparts. For instance, the interleukin-1beta receptor [32], interferon-gamma receptor [33], and 3beta-hydroxy-steroid dehydrogenase [34] from VACV share 33%, 25%, and 44% aa identity with their human orthologues, respectively. Therefore, compared to other orthopoxvirus immunomodulators, v-GAAP shows by far the greatest amino acid similarity with its mammalian counterpart. The close relationship of the GAAPs in VACV and mammals suggests that either the gene has been captured from the host more recently in evolution, or that functional constraints have restricted its divergence after acquisition.
###end p 45
###begin p 46
Third, v-GAAP (and h-GAAP) inhibits apoptosis induced by an unusually broad range of pro-apoptotic stimuli from both the extrinsic and intrinsic pathways. Instrinsic pro-apoptotic stimuli inhibited by GAAPs include bax, staurosporine, doxorybicin, cisplatin, and ceramide. Extrinsic stimuli inhibited include Fas and TNF. The mechanism by which GAAPs inhibit apoptosis remains to be determined. The ability of GAAPs to inhibit cell death induced by various instrinsic apoptotic stimuli suggests strongly that it acts at a step in the mitochondrial pathway. The finding that h-GAAP suppressed TNF-induced apoptosis at a step downstream of caspase-8 activation is consistent with this idea.
###end p 46
###begin p 47
###xml 138 151 138 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Homo sapiens,</italic>
###xml 119 123 <span type="species:ncbi:10245">VACV</span>
###xml 138 150 <span type="species:ncbi:9606">Homo sapiens</span>
###xml 303 308 <span type="species:ncbi:9606">human</span>
###xml 398 403 <span type="species:ncbi:9606">human</span>
In summary, a new regulator of apoptosis has been discovered by the study of poxviruses. The protein, called v-GAAP in VACV and h-GAAP in Homo sapiens, is highly conserved in eukaryotes, and is another example of a host gene acquired during virus evolution to combat the host response to infection. The human protein is essential for cell viability, and in its absence cells die by apoptosis. Both human and viral GAAPs inhibit an unusually wide range of pro-apoptotic stimuli. The viral protein affects virus virulence and can also substitute for the h-GAAP to maintain cell viability.
###end p 47
###begin title 48
Materials and Methods
###end title 48
###begin title 49
Cells and viruses.
###end title 49
###begin p 50
###xml 32 33 32 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 307 308 307 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030017-b008">8</xref>
###xml 309 311 309 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030017-b027">27</xref>
###xml 18 23 <span type="species:ncbi:9606">human</span>
###xml 213 219 <span type="species:ncbi:9913">bovine</span>
###xml 241 245 <span type="species:ncbi:10245">VACV</span>
###xml 263 267 <span type="species:ncbi:28873">CMLV</span>
Monkey BS-C-1 and human HeLa, TK-143, U2OS (osteosarcoma, p53 wild-type), and Saos2 (osteosarcoma, p53-null) cells were grown in Dublbecco's modified Eagle's medium (Gibco, ) with 10% (v/v) heat-inactivated fetal bovine serum. The source of VACV strain Evans and CMLV strain CM-S were described previously [8,27].
###end p 50
###begin title 51
GAAPs antiserum.
###end title 51
###begin p 52
###xml 172 179 <span type="species:ncbi:9986">rabbits</span>
###xml 306 311 <span type="species:ncbi:9606">human</span>
The peptide sequence SSIEDDFNYGSSV (h-GAAP aa 11-23 and v-GAAP aa 10-22) was conjugated to keyhole limpet hemocyanin via a C-terminal cysteine residue and used to immunize rabbits (Sigma-Genosys, ). The specificity of the Ab was confirmed by immunofluorescence using U2OS cells stably expressing HA-tagged human or viral GAAPs showing that the signal obtained is identical to the signal given by the anti-HA monoclonal antibody (mAb).
###end p 52
###begin title 53
Tissue expression profile of h-GAAP.
###end title 53
###begin p 54
###xml 68 73 <span type="species:ncbi:9606">Human</span>
The presence of h-GAAP mRNA in different tissues was analyzed using Human Multiple Tissue cDNA panels I and II (Clontech, ) and semi-quantitative RT-PCR with Platinum PCR SuperMix (Invitrogen, ). cDNAs were amplified with h-GAAP specific primers. To define the optimal number of PCR cycles for linear amplification, an aliquot from each of the samples was removed at 20 cycles, and thereafter at every fifth additional cycle.
###end p 54
###begin title 55
###xml 11 16 <span type="species:ncbi:9606">human</span>
Cloning of human and viral GAAPs.
###end title 55
###begin p 56
###xml 90 96 90 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v-GAAP</italic>
###xml 318 324 318 324 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAATTC</underline>
###xml 331 334 331 334 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ATG</bold>
###xml 372 378 372 378 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTCGAG</underline>
###xml 378 381 378 381 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAA</bold>
###xml 0 4 <span type="species:ncbi:28873">CMLV</span>
###xml 21 25 <span type="species:ncbi:10245">VACV</span>
CMLV strain CM-S and VACV strain Evans genomic DNA were used for PCR amplification of the v-GAAP genes with the influenza virus HA epitope YPYDVPDYA encoded at the 3' end. These fragments were cloned into the plasmid pCDNA3.1 (Invitrogen). Oligonucleotides were identical for both viral proteins: v-GAAP exp1 (5'-GCCCCGAATTCCGCCGCCATGGCAATGCCG) and v-GAAP exp2-HA (5'-GCCCCTCGAGTAAagcgtaatcaggcacgtcgtaagggtaTTTCTTATTAGATACTTCCAAAAGC). Bold, underlined, or lower case nucleotides represent the translation initiation and termination codons, restriction sites, and HA tag, respectively.
###end p 56
###begin p 57
###xml 8 14 8 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">h-GAAP</italic>
###xml 202 208 202 208 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAATTC</underline>
###xml 215 218 215 218 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ATG</bold>
###xml 256 262 256 262 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTCGAG</underline>
###xml 262 265 262 265 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TTA</bold>
###xml 574 579 <span type="species:ncbi:9606">human</span>
For the h-GAAP gene, total RNA was isolated from HeLa cells and h-GAAP cDNA was cloned by RT-PCR into pCDNA3.1 using the ThermoScript RT-PCR System (Invitrogen) and oligonucleotides h-GAAPexp1 (5'-GCCCCGAATTCTGCCATCATGGCTGACCCCG) and h-GAAPexp2HA (5'- GCCCCTCGAGTTAagcgtaatcaggcacgtcgtaagggtaCTTTTTATTAACTGCTTCCAGAAACC). Bold, underlined, or lower case nucleotides represent the translation initiation and termination codons, restriction sites, and HA tag, respectively. The fidelity of all DNA sequences was confirmed by sequencing. For transient transfection experiments, human and viral GAAPs cDNA were subcloned into pCI (Promega, ).
###end p 57
###begin title 58
Construction of GAAP mutant viruses.
###end title 58
###begin p 59
###xml 26 30 26 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAAP</italic>
###xml 122 124 122 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030017-b035">35</xref>
###xml 235 239 235 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAAP</italic>
###xml 290 296 286 292 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GTCGAC</underline>
###xml 341 354 333 346 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCAATCCATGTTT</bold>
###xml 412 426 400 414 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAATATATAGGTCA</bold>
###xml 466 472 450 456 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAATTC</underline>
###xml 733 735 709 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030017-b036">36</xref>
###xml 2 6 <span type="species:ncbi:10245">VACV</span>
A VACV mutant lacking the GAAP gene was constructed using a plasmid assembled by splicing by overlap extension (SOE)-PCR [35]. Two DNA fragments were amplified representing either the 5' (307 bp) or 3' (462 bp) flanking regions of the GAAP gene, using oligonucleotides DeltaGAAP-1 (5'-GCCCCGTCGACGATGTGATAAATACAGCGATACC) and DeltaGAAP-2 (5'-CCAATCCATGTTTTGACCTATATATTAATACTC) or oligonucleotides DeltaGAAP-3 (5'-TAATATATAGGTCAAAACATGGATTGGAAAC) and DeltaGAAP-4 (CGGGGAATTCGTAGCGTGGCAATGACAG), respectively. Annealing regions are shown in bold and restriction sites are underlined. The 5' and 3' GAAP deletion fragments were joined by SOE-PCR using oligonucleotides DeltaGAAP-1 and DeltaGAAP-4, and the product was cloned into pSJH7 [36], forming pSJH7-DeltaGAAP.
###end p 59
###begin p 60
###xml 51 55 51 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAAP</italic>
###xml 439 460 419 440 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AGCGTAATCAGGCACGTCGTA</bold>
###xml 516 537 492 513 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TACGACGTGCCTGATTACGCT</bold>
###xml 137 141 <span type="species:ncbi:10245">VACV</span>
###xml 259 263 <span type="species:ncbi:10245">VACV</span>
###xml 595 599 <span type="species:ncbi:10245">VACV</span>
To make a revertant virus, a wild-type copy of the GAAP gene was amplified by PCR using oligonucleotides DeltaGAAP-1 and DeltaGAAP-4 and VACV Evans genomic DNA as template. This product was cloned into pSJH7, forming pSJH7-GAAP-Rev. For the construction of a VACV expressing v-GAAP with a C-terminal HA tag, plasmid pSJH7-GAAPRevHA was constructed by SOE-PCR as for pSJH7-DeltaGAAP using oligonucleotides DeltaGAAP-1, DeltaGAAP-2RevHA (5'-AGCGTAATCAGGCACGTCGTAAGGGTATTTCTTATTAGATACTTCCAAAAGC), DeltaGAAP-3RevHA (5'- TACGACGTGCCTGATTACGCTTAAAGTTTAAAATAGAATTAATAAAAACATATAGG), and DeltaGAAP-4 and VACV genomic DNA as template.
###end p 60
###begin p 61
###xml 70 71 70 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030017-b006">6</xref>
###xml 83 99 83 99 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Escherichia coli</named-content>
###xml 183 185 183 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030017-b037">37</xref>
###xml 436 440 428 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A41L</italic>
###xml 447 449 439 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030017-b038">38</xref>
###xml 820 822 808 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030017-b039">39</xref>
###xml 83 99 <span type="species:ncbi:562">Escherichia coli</span>
###xml 269 273 <span type="species:ncbi:10245">VACV</span>
###xml 431 435 <span type="species:ncbi:10245">VACV</span>
###xml 570 574 <span type="species:ncbi:10245">VACV</span>
Recombinant viruses were constructed by transient dominant selection [6] using the Escherichia coli guanine xanthine phosphoribosyltransferase (Ecogpt) gene as the selectable marker [37]. Briefly, pSJH7-DeltaGAAP was transfected into CV-1 cells that were infected with VACV Evans, and a deletion mutant (v-DeltaGAAP) and a wild-type control virus (v-GAAP WT) derived from the same intermediate virus were isolated as described for VACV A41L gene [38]. A revertant virus with or without an HA tag (v-GAAP Rev and v-GAAP RevHA) were constructed in a similar manner, using VACV v-DeltaGAAP as parent virus and plasmids pSJH7-GAAPRev and pSJH7-GAAPRevHA, respectively. All virus isolates were plaque-purified three times and the virus genomes were analysed by Southern blotting and PCR using DNA extracted from virus cores [39].
###end p 61
###begin title 62
Stable cell lines.
###end title 62
###begin p 63
###xml 75 80 <span type="species:ncbi:9606">human</span>
U2OS cells were transfected with either the pCDNA3.1- or pCDNA3.1-encoding human or viral GAAPs-HA using Lipofectamine (Invitrogen); 48 h post-transfection, cells were treated with 500 mug/ml of G418. After 1 mo, isolated colonies were cloned and the expression of transfected sequences was determined by immunofluorescence and immunoblotting. Staurosporine- and Fas-induced apoptosis assays (see apoptosis assay section below) were carried out with two independent U2OS-v-GAAP clones or three independent U2OS-h-GAAP clones. Each clone gave similar results to those shown for the two clones described throughout the paper.
###end p 63
###begin title 64
Flow cytometry.
###end title 64
###begin p 65
###xml 16 17 16 17 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 313 315 310 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030017-b040">40</xref>
Saos-2 cells (106) were seeded in 10-cm diameter plates; after 24 h, cells were transfected with plasmids expressing CD20 (2 mug), Bax (5 mug), and 15 mug of pCI or pCI-v-GAAP or pCI-h-GAAP-HA as indicated. Then, 36 h after transfection, both attached and floating cells were harvested and analyzed as described [40].
###end p 65
###begin title 66
Apoptosis assays.
###end title 66
###begin p 67
###xml 48 49 48 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 357 358 347 348 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 481 482 471 472 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 491 492 481 482 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 495 496 485 486 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 598 599 588 589 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 633 634 622 623 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 218 223 <span type="species:ncbi:9606">human</span>
Cells were seeded into 6-well dishes at 4-6 x 105 cells/well. One day later, cells were treated with 3 muM staurosporine, 10 mg/ml cisplatin, 500 ng/ml anti-Fas Ab (Clone CH11; Upstate Biotechnology, ), or 10 ng/ml of human TNF-alpha (PeproTech EC, ). Fas and TNF-alpha were used in combination with 10 mug/ml of CHX (Sigma). For induction of apoptosis by C2-ceramide (N-acetyl-D-sphingosine, Sigma), cells were preincubated in modified KRB buffer (125 mM NaCl, 5 mM KCl, 1 mM MgSO4, 1 mM Na2HPO4, 5.5 mM glucose, 20 mM NaHCO3, 2 mM L-glutamine, and 20 mM HEPES [pH7.4]) supplemented with 1 mM CaCl2 for 4 h and treated with 10 muM C2-ceramide in the same medium. At the indicated time post all treatments, both attached and floating cells were harvested using 4 mM EDTA/PBS. The DNA content of all the cells was analyzed using flow cytometry as described above.
###end p 67
###begin title 68
Immunofluorescence.
###end title 68
###begin p 69
###xml 130 132 130 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030017-b041">41</xref>
###xml 810 812 790 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030017-b042">42</xref>
###xml 296 300 <span type="species:ncbi:10245">VACV</span>
###xml 574 579 <span type="species:ncbi:10090">mouse</span>
###xml 614 617 <span type="species:ncbi:10116">rat</span>
###xml 676 682 <span type="species:ncbi:9986">rabbit</span>
###xml 702 707 <span type="species:ncbi:10090">mouse</span>
###xml 780 785 <span type="species:ncbi:10090">mouse</span>
HeLa, U2OS-neo, U2OS-v-GAAP, or U2OS-h-GAAP cells were grown on coverslips, and intracellular proteins were stained as described [41]. For detection of endogenous h-GAAP, cells were fixed with 3% PFA in PBS on ice for 20 min, and permeabilised and stained as above. For detection of v-GAAP after VACV infection, HeLa cells were infected at 10 pfu/cell and fixed as above 4 h p.i. Samples were examined with a Zeiss LSM 510 laser scanning confocal microscope. Images were captured and processed using Zeiss LSM Image Browser version 3.1.0.99 (). Primary antibodies used were mouse alpha-HA mAb (1:1000; Covance, ), rat high affinity alpha-HA mAb (clone 3F10, 1:1000; Roche, ), rabbit alpha-GAAP (1:50), mouse alpha-GM130 (1:100, BD Transduction Laboratories; BD Biosciences, ), or mouse alpha-A36R mAb (1:100, [42]).
###end p 69
###begin title 70
Electron microscopy.
###end title 70
###begin p 71
###xml 104 106 104 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030017-b043">43</xref>
For conventional electron microscopy and for cryo-immunocytochemistry, cells were treated as described [43]. All images were acquired on a FEI Tecnai G2 electron microscope () using a MegaView III CCD camera (Olympus Soft Imaging Solutions, ) operating under analySIS Docu software.
###end p 71
###begin title 72
Immunoblotting.
###end title 72
###begin p 73
###xml 122 124 121 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030017-b041">41</xref>
###xml 156 162 <span type="species:ncbi:9986">rabbit</span>
###xml 183 188 <span type="species:ncbi:10090">mouse</span>
###xml 221 224 <span type="species:ncbi:10116">rat</span>
###xml 301 306 <span type="species:ncbi:10090">mouse</span>
Cells were lysed in RIPA or LDL buffer and between 50 and 200 mug of protein was analyzed by immunoblotting as described [41]. Primary antibodies used were rabbit alpha-GAAP (1:200), mouse alpha-HA mAb (1:1000; Covance), rat alpha-alpha tubulin (YL1/2, 1:2000; Serotec, http://www.ab-direct.com), and mouse alpha-cleaved PARP (Asp214) mAb (1:1000, 19F4; Cell Signaling Technology, ).
###end p 73
###begin title 74
RNAi transfection.
###end title 74
###begin p 75
###xml 67 69 67 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030017-b044">44</xref>
###xml 70 72 70 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030017-b045">45</xref>
###xml 571 573 570 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030017-b046">46</xref>
siRNA sequences specific to h-GAAP were designed using "siDIRECT" [44,45] and were from Ambion (). GAAP siRNA1: 5'- CGAUCGAGGACGACUUCAACU-3' (sense) and 5'- UUGAAGUCGUCCUCGAUCGAG-3' (antisense); GAAP siRNA2: 5'- CUGUACGGACAUUUGUACAUG-3' (sense) and 5'- UGUACAAAUGUCCGUACAGAC-3' (antisense); GAAP siRNA3: 5'- CGGAUCUCUGGGUUUGAUUUU-3' (sense) and 5'- AAUCAAACCCAGAGAUCCGAG-3' (antisense). As a control, siRNA to GFP (Dharmacon, ) was used. Cells were grown to 50% confluency in 6-well plates and transfected with 1 mug of siRNAs using siFECTamine (IC-Vec, United Kingdom) [46]. The transfection efficiency was determined to be >97% using siFECTamine labeled with Dioleoyl-sn-Glycero-3-Phosphoethanolamine-N-(Lissamine-Rhodamine-B-Sulfonyl) (IC-Vec) by flow cytometry and immunofluorescence analysis (unpublished data).
###end p 75
###begin title 76
Semi-quantitative RT-PCR.
###end title 76
###begin p 77
For semi-quantitative RT-PCR after siRNA transfection, total RNA was extracted from HeLa cells using TRIzol reagent (Invitrogen) and treated with Amplification grade DNAseI (Invitrogen) before semi-quantitative RT-PCR analysis was performed using the SuperScriptTM III One-Step RT-PCR System (Invitrogen). Each reaction contained 0.2 mug of total RNA and the optimal number of cycles for linear amplification for tissue expression analysis. Primers were h-GAAP forward: 5'-GCCCCGAATTCTGCCATCATGGCTGACCCCG-3' and reverse: 5'-GCCCCTCGAGTTACTTTTTATTAACTGCTTCCAGAAACC-3'; and actin forward: 5'-GTGGGGCGCCCCAGGCACCA-3' and reverse 5'-CTCCTTAATGTCACGCACGATTTC-3'.
###end p 77
###begin p 78
###xml 69 70 69 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 39 43 <span type="species:ncbi:10245">VACV</span>
###xml 113 117 <span type="species:ncbi:28873">CMLV</span>
To determine the time of expression of VACV GAAP during infection, TK-143 cells were infected with 5 pfu/cell of CMLV with or without 40 mug/ml AraC. After 2, 5, or 22 h, total RNA was extracted from cells using the RNEasy Midi kit (Qiagen, ) treated with Amplification Grade DNAseI (Invitrogen). Semi-quntitative RT-PCR analysis was performed as above. Primers were v-GAAP exp1, v-GAAP exp2, D8L-1 (5'-GTCTCTCTCAAATCGGAC), and D8L-2 (5'-GCAAAAAAAACACGATGA).
###end p 78
###begin title 79
Mitochondrial membrane potential.
###end title 79
###begin p 80
Mitochondrial membrane potential was quantified by staining with TMRE (Molecular Probes, ). Cells were loaded with TMRE by incubating cells in medium containing 0.2 muM TMRE for 30 min at 37 degreesC. TMRE fluorescence was acquired using flow cytometry through the FL-2 channel.
###end p 80
###begin title 81
###xml 45 49 <span type="species:ncbi:10090">mice</span>
Virulence assays of v-GAAP mutant viruses in mice.
###end title 81
###begin p 82
###xml 207 209 206 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030017-b027">27</xref>
###xml 662 663 661 662 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 676 677 675 676 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 689 690 688 689 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 44 48 <span type="species:ncbi:10090">mice</span>
###xml 140 144 <span type="species:ncbi:10090">mice</span>
###xml 338 342 <span type="species:ncbi:10090">mice</span>
For intranasal infections, groups of BALB/c mice (6-8 wk old) were inoculated under general anaesthesia with virus in 20 mul PBS. Each day, mice were weighed individually and monitored for signs of illness [27], and those suffering a severe infection or having lost 30% of their original body weight were sacrificed. To obtain BAL fluid, mice were killed and their lungs were inflated five times with 1.5 ml of 12 mM lidocaine and 5 mM EDTA in Earle's Balanced Salt Solution (Sigma) through a blunted 23-gauge needle inserted into the trachea. BAL fluids were centrifuged (2,000 rpm, 10 min) and the cells were re-suspended in erythrocyte lysis buffer (0.829% NH4Cl, 0.1% KHCO3, 0.0372% Na2EDTA, [pH 7.2]) for 5 min at RT. Cells were washed with RPMI 1640 medium (Gibco) and cell viability was assessed using trypan blue exclusion.
###end p 82
###begin title 83
Statistical analysis.
###end title 83
###begin p 84
###xml 14 15 14 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
The Student's t-test (two-tailed) was used to test the significance of the results.
###end p 84
###begin title 85
Supporting Information
###end title 85
###begin title 86
Protein Trafficking to the Cell Surface Is Not Affected by GAAPs
###end title 86
###begin p 87
###xml 85 111 <span type="species:ncbi:11276">vesicular stomatitis virus</span>
U2OS-neo, U2OS-v-GAAP, or U2OS-h-GAAP cells were transfected with a plasmid encoding vesicular stomatitis virus glycoprotein G fused to GFP and were fixed for analysis by fluorescence microscopy 4, 7, and 24 h post transfection.
###end p 87
###begin p 88
Scale bars, 20 mum.
###end p 88
###begin p 89
(584 KB PPT)
###end p 89
###begin p 90
Click here for additional data file.
###end p 90
###begin title 91
###xml 19 24 <span type="species:ncbi:9606">Human</span>
Down-Regulation of Human GAAP Induces Loss of Mitochondrial Membrane Potential
###end title 91
###begin p 92
HeLa cells, mock-transfected or transfected with h-GAAP siRNAs 1-3 for 56 h, were loaded with the mitochondrial membrane potential sensor TMRE. Loss of mitochondrial membrane potential was measured as a decrease in TMRE fluorescence by two-color flow cytometry (cell population labeled M1).
###end p 92
###begin p 93
(76 KB PPT)
###end p 93
###begin p 94
Click here for additional data file.
###end p 94
###begin title 95
Accession Numbers
###end title 95
###begin p 96
###xml 78 89 78 89 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">A. thaliana</named-content>
###xml 163 178 163 178 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">D. melanogaster</named-content>
###xml 400 409 400 409 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">X. laevis</named-content>
###xml 78 89 <span type="species:ncbi:3702">A. thaliana</span>
###xml 108 112 <span type="species:ncbi:28873">CMLV</span>
###xml 142 145 <span type="species:ncbi:9615">dog</span>
###xml 163 178 <span type="species:ncbi:7227">D. melanogaster</span>
###xml 270 275 <span type="species:ncbi:10090">mouse</span>
###xml 291 300 <span type="species:ncbi:9600|species:ncbi:9601">orangutan</span>
###xml 316 320 <span type="species:ncbi:10245">VACV</span>
###xml 344 348 <span type="species:ncbi:10245">VACV</span>
###xml 373 377 <span type="species:ncbi:10245">VACV</span>
###xml 400 409 <span type="species:ncbi:8355">X. laevis</span>
###xml 431 440 <span type="species:ncbi:7955">zebrafish</span>
The Genbank () accession numbers for the proteins discussed in this paper are A. thaliana GAAP (NP_193209), CMLV strain CM-S GAAP (AAG37461), dog GAAP (XP531662), D. melanogaster GAAP (Q9V6H6); h-GAAP (CGI-119, AAD34114; S1R protein, AAF14868; and z-protein, AF182041), mouse GAAP (Q9DA39), orangutan GAAP (Q5R8M0), VACV Evans GAAP (AY690669), VACV Lister GAAP (AY699305), VACV USSR GAAP (AY699306), X. laevis GAAP (AAH90219), and zebrafish GAAP (Q5TZH2).
###end p 96
###begin title 97
Abbreviations
###end title 97
###begin p 98
amino acid(s)
###end p 98
###begin p 99
antibody
###end p 99
###begin p 100
cytosine arabinoside
###end p 100
###begin p 101
bronchoalveolar lavage
###end p 101
###begin p 102
base pair
###end p 102
###begin p 103
complementary DNA
###end p 103
###begin p 104
cycloheximide
###end p 104
###begin p 105
###xml 0 14 <span type="species:ncbi:28873">camelpox virus</span>
camelpox virus
###end p 105
###begin p 106
endoplasmic reticulum
###end p 106
###begin p 107
Golgi anti-apoptotic protein
###end p 107
###begin p 108
green fluorescent protein
###end p 108
###begin p 109
hemagglutinin
###end p 109
###begin p 110
###xml 0 5 <span type="species:ncbi:9606">human</span>
human Golgi anti-apoptotic protein
###end p 110
###begin p 111
monoclonal antibody
###end p 111
###begin p 112
messenger RNA
###end p 112
###begin p 113
poly (adenosine diphosphate-ribose) polymerase
###end p 113
###begin p 114
plaque-forming unit
###end p 114
###begin p 115
post infection
###end p 115
###begin p 116
reverse transcription PCR
###end p 116
###begin p 117
standard deviation
###end p 117
###begin p 118
small interfering RNA
###end p 118
###begin p 119
tetramethylrhodamine ethyl ester
###end p 119
###begin p 120
tumour necrosis factor
###end p 120
###begin p 121
###xml 0 14 <span type="species:ncbi:10245">vaccinia virus</span>
vaccinia virus
###end p 121
###begin p 122
viral Golgi anti-apoptotic protein
###end p 122
###begin title 123
References
###end title 123
###begin article-title 124
Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics
###end article-title 124
###begin article-title 125
Organelle-specific initiation of cell death pathways
###end article-title 125
###begin article-title 126
The PIDDosome, a protein complex implicated in activation of caspase-2 in response to genotoxic stress
###end article-title 126
###begin article-title 127
The endoplasmic reticulum gateway to apoptosis by Bcl-X(L) modulation of the InsP(3)R
###end article-title 127
###begin article-title 128
Golgi structure in stress sensing and apoptosis
###end article-title 128
###begin article-title 129
Transient dominant selection of recombinant vaccinia viruses
###end article-title 129
###begin article-title 130
###xml 16 30 <span type="species:ncbi:28873">camelpox virus</span>
###xml 67 80 <span type="species:ncbi:10255">variola virus</span>
###xml 95 103 <span type="species:ncbi:10255">smallpox</span>
The sequence of camelpox virus shows it is most closely related to variola virus, the cause of smallpox
###end article-title 130
###begin article-title 131
Poxviruses and immune evasion
###end article-title 131
###begin article-title 132
Near death experiences: Poxvirus regulation of apoptotic death
###end article-title 132
###begin article-title 133
Pfam: A comprehensive database of protein domain families based on seed alignments
###end article-title 133
###begin article-title 134
###xml 36 41 <span type="species:ncbi:9606">human</span>
Identification of a novel conserved human gene, TEGT
###end article-title 134
###begin article-title 135
BI-1 regulates an apoptosis pathway linked to endoplasmic reticulum stress
###end article-title 135
###begin article-title 136
###xml 88 93 <span type="species:ncbi:4932">yeast</span>
Bax inhibitor-1, a mammalian apoptosis suppressor identified by functional screening in yeast
###end article-title 136
###begin article-title 137
LFG: An anti-apoptotic gene that provides protection from Fas-mediated cell death
###end article-title 137
###begin article-title 138
###xml 0 14 <span type="species:ncbi:10245">Vaccinia virus</span>
Vaccinia virus gene D8 encodes a virion transmembrane protein
###end article-title 138
###begin article-title 139
###xml 21 29 <span type="species:ncbi:10255">smallpox</span>
An attenuated LC16m8 smallpox vaccine: Analysis of full-genome sequence and induction of immune protection
###end article-title 139
###begin article-title 140
###xml 0 14 <span type="species:ncbi:10245">Vaccinia virus</span>
Vaccinia virus gene A36R encodes a M(r) 43-50 K protein on the surface of extracellular enveloped virus
###end article-title 140
###begin article-title 141
Doxorubicin-induced apoptosis is associated with increased transcription of endothelial nitric-oxide synthase. Effect of antiapoptotic antioxidants and calcium
###end article-title 141
###begin article-title 142
Cisplatin induces endoplasmic reticulum stress and nucleus-independent apoptotic signaling
###end article-title 142
###begin article-title 143
Bax and Bak promote apoptosis by modulating endoplasmic reticular and mitochondrial Ca2+ stores
###end article-title 143
###begin article-title 144
BAX and BAK regulation of endoplasmic reticulum Ca2+: A control point for apoptosis
###end article-title 144
###begin article-title 145
Regulation of endoplasmic reticulum Ca2+ dynamics by proapoptotic BCL-2 family members
###end article-title 145
###begin article-title 146
###xml 25 29 <span type="species:ncbi:10090">mice</span>
###xml 35 49 <span type="species:ncbi:10245">vaccinia virus</span>
Respiratory infection of mice with vaccinia virus
###end article-title 146
###begin article-title 147
###xml 63 67 <span type="species:ncbi:10090">mice</span>
Biological characterization of recombinant vaccinia viruses in mice infected by the respiratory route
###end article-title 147
###begin article-title 148
###xml 53 67 <span type="species:ncbi:10245">vaccinia virus</span>
A soluble receptor for interleukin-1 beta encoded by vaccinia virus: A novel mechanism of virus modulation of the host response to infection
###end article-title 148
###begin article-title 149
###xml 55 59 <span type="species:ncbi:10090">mice</span>
###xml 74 88 <span type="species:ncbi:10245">vaccinia virus</span>
A kinetic analysis of immune mediators in the lungs of mice infected with vaccinia virus and comparison with intradermal infection
###end article-title 149
###begin article-title 150
Viral mimicry of cytokines, chemokines and their receptors
###end article-title 150
###begin article-title 151
Golgi disassembly in apoptosis: cause or effect?
###end article-title 151
###begin article-title 152
Gene expression profiling predicts clinical outcome of breast cancer
###end article-title 152
###begin article-title 153
###xml 4 18 <span type="species:ncbi:10245">vaccinia virus</span>
Two vaccinia virus proteins structurally related to the interleukin-1 receptor and the immunoglobulin superfamily
###end article-title 153
###begin article-title 154
Vaccinia, cowpox, and camelpox viruses encode soluble gamma interferon receptors with novel broad species specificity
###end article-title 154
###begin article-title 155
Steroid hormone synthesis by a vaccinia enzyme: A new type of virus virulence factor
###end article-title 155
###begin article-title 156
Engineering hybrid genes without the use of restriction enzymes: Gene splicing by overlap extension
###end article-title 156
###begin article-title 157
###xml 86 110 86 110 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Saccharomyces cerevisiae</named-content>
###xml 0 14 <span type="species:ncbi:10245">Vaccinia virus</span>
###xml 86 110 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Vaccinia virus encodes an active thymidylate kinase that complements a cdc8 mutant of Saccharomyces cerevisiae
###end article-title 157
###begin article-title 158
A dominant selectable marker for the construction of recombinant poxviruses
###end article-title 158
###begin article-title 159
###xml 4 18 <span type="species:ncbi:10245">vaccinia virus</span>
The vaccinia virus A41L protein is a soluble 30 kDa glycoprotein that affects virus virulence
###end article-title 159
###begin article-title 160
The preparation of orthopoxvirus DNA
###end article-title 160
###begin article-title 161
ASPP proteins specifically stimulate the apoptotic function of p53
###end article-title 161
###begin article-title 162
###xml 0 23 <span type="species:ncbi:132475">Yaba-like disease virus</span>
Yaba-like disease virus protein Y144R, a member of the complement control protein family, is present on enveloped virions that are associated with virus-induced actin tails
###end article-title 162
###begin article-title 163
###xml 4 18 <span type="species:ncbi:10245">vaccinia virus</span>
The vaccinia virus A36R protein is a type Ib membrane protein present on intracellular but not extracellular enveloped virus particles
###end article-title 163
###begin article-title 164
###xml 0 14 <span type="species:ncbi:10245">Vaccinia virus</span>
Vaccinia virus intracellular mature virions contain only one lipid membrane
###end article-title 164
###begin article-title 165
###xml 83 88 <span type="species:ncbi:9031">chick</span>
Guidelines for the selection of highly effective siRNA sequences for mammalian and chick RNA interference
###end article-title 165
###begin article-title 166
siDirect: Highly effective, target-specific siRNA design software for mammalian RNA interference
###end article-title 166
###begin article-title 167
Lipidic carriers of siRNA: Differences in the formulation, cellular uptake, and delivery with plasmid DNA
###end article-title 167
###begin article-title 168
CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice
###end article-title 168
###begin article-title 169
WinGene/WinPep: User-friendly software for the analysis of amino acid sequences
###end article-title 169
###begin title 170
Figures and Tables
###end title 170
###begin title 171
GAAPs Are Evolutionarily Conserved
###end title 171
###begin p 172
###xml 14 16 14 16 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030017-b047">47</xref>
###xml 158 168 158 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X. laevis,</italic>
###xml 180 192 180 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A. thaliana,</italic>
###xml 197 212 197 212 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">D. melanogaster</named-content>
###xml 91 95 <span type="species:ncbi:10245">VACV</span>
###xml 110 114 <span type="species:ncbi:28873">CMLV</span>
###xml 128 133 <span type="species:ncbi:9606">human</span>
###xml 135 144 <span type="species:ncbi:9600|species:ncbi:9601">orangutan</span>
###xml 146 149 <span type="species:ncbi:9615">dog</span>
###xml 151 156 <span type="species:ncbi:10090">mouse</span>
###xml 158 167 <span type="species:ncbi:8355">X. laevis</span>
###xml 169 178 <span type="species:ncbi:7955">zebrafish</span>
###xml 180 191 <span type="species:ncbi:3702">A. thaliana</span>
###xml 197 212 <span type="species:ncbi:7227">D. melanogaster</span>
(A) CLUSTALW [47] alignment of h-GAAP and v-GAAP with related proteins from other species: VACV strain Evans, CMLV strain CM-S, human, orangutan, dog, mouse, X. laevis, zebrafish, A. thaliana, and D. melanogaster. Identical residues are shown in black, and residues conserved in six to eight or nine out of ten sequences are in light or dark grey, respectively. Horizontal bars show predicted transmembrane domains (I-VII) based on the Kyte-Doolittle hydropathy model. An asterisk denotes a block of 20 aa.
###end p 172
###begin p 173
###xml 48 59 48 59 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">A. thaliana</named-content>
###xml 133 135 133 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030017-b048">48</xref>
###xml 31 36 <span type="species:ncbi:9606">human</span>
###xml 38 42 <span type="species:ncbi:10245">VACV</span>
###xml 48 59 <span type="species:ncbi:3702">A. thaliana</span>
(B) Hydrophobicity profiles of human, VACV, and A. thaliana GAAPs according to Kyte and Doolittle, plotted using the program WinPep [48]. Putative transmembrane domains (I-VII) are outlined.
###end p 173
###begin title 174
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human and Viral GAAPs Are Golgi Proteins
###end title 174
###begin p 175
###xml 113 114 113 114 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 170 174 170 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">110L</italic>
###xml 200 203 200 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D8L</italic>
###xml 291 292 291 292 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 97 101 <span type="species:ncbi:28873">CMLV</span>
###xml 160 164 <span type="species:ncbi:28873">CMLV</span>
###xml 190 194 <span type="species:ncbi:10245">VACV</span>
###xml 340 344 <span type="species:ncbi:10245">VACV</span>
(A) Time of v-GAAP expression during infection. Semi-quantitative RT-PCR (30 cycles) analysis of CMLV-infected TK-143 cells for presence of mRNA for v-GAAP and CMLV gene 110L (equivalent to VACV gene D8L) (left panel). The right panel shows an immunoblot analysis of v-GAAP RevHA-infected TK-143 cells for expression of v-GAAP and the late VACV protein A36 using alpha-HA and alpha-A36 mAbs, respectively. m, mock.
###end p 175
###begin p 176
(B) v-GAAP localises to the Golgi. HeLa cells were infected with v-GAAP WT, v-DeltaGAAP, and v-GAAP Rev for 6 h and stained for v-GAAP using anti-GAAP Ab and for Golgi using anti-GM130 Ab. Scale bars, 20 mum. The right panel shows an immunoblot analysis of v-GAAP mutant viruses 16 h p.i. using the alpha-GAAP Ab. The black arrow (left panel) indicates the GAAP protein.
###end p 176
###begin p 177
###xml 52 58 52 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">h-GAAP</italic>
###xml 213 218 <span type="species:ncbi:9606">human</span>
(C) Tissue expression profile of h-GAAP. The 714-bp h-GAAP gene (35 cycles, top panel) or 983-bp glyceraldehyde-3-phosphate dehydrogenase (G3PDH) gene fragment (30 cycles, bottom panel) were amplified by PCR from human cDNA master panels and analyzed by agarose gel electrophoresis. intestine, small intestine; PBL, peripheral blood leukocyte; sk. muscle, skeletal muscles.
###end p 177
###begin p 178
(D) h-GAAP localises to the Golgi. HeLa cells were stained for endogenous h-GAAP and Golgi marker GM130 using anti-GAAP and anti-GM130-specific Abs. Scale bars, 20 mum. Pre-immune serum was used as a control (right panel).
###end p 178
###begin title 179
Location of GAAPs
###end title 179
###begin p 180
(A) U2OS-neo (top row), U2OS-v-GAAP (middle row), or U2OS-h-GAAP (lower row) cells were stained using an anti-HA mAb together with an alpha-GM130 Ab. All primary Abs were detected with secondary Abs conjugated to fluorescein isothiocyanate or tetramethylrhodamine isothiocyanate. Scale bars, 20 mum. The right panel shows an immunoblot analysis of U2OS stable cell lines using an alpha-HA mAb.
###end p 180
###begin p 181
###xml 173 179 <span type="species:ncbi:9986">rabbit</span>
###xml 185 190 <span type="species:ncbi:10090">mouse</span>
(B) Top left panel: Cryo-immunoelectron microscopy was used to label the v-GAAP HA-tagged protein in U2OS v-GAAP cells with anti-HA mAb (Covance, diluted 1/10), followed by rabbit anti-mouse (Cappel) and 6-nm protein-A Au (scale bars 100 nm, top left panel). Golgi stack morphology was compared in the different cell lines by conventional thin sections of Epon-embedded samples and was examined by electron microscopy in U2OS-neo (top right panel), US-OS-v-GAAP (lower left panel), and U2OS h-GAAP (lower right panel). Scale bars, 200 nm.
###end p 181
###begin p 182
(C) HeLa cells were transfected with pCI-h-GAAPHA or pCI-v-GAAPHA and fixed 4 h post transfection. GAAPs were detected using an alpha-HA mAb, and cells were co-stained with the Golgi marker alpha-GM130. Scale bars, 20 mum.
###end p 182
###begin title 183
Downregulation of h-GAAP Causes Cell Death by Appotosis
###end title 183
###begin p 184
HeLa cells (A-D) or U2OS-h-GAAP cells (E and F) were transfected with siRNA oligos directed to h-GAAP (siRNAs 1-3) or GFP (GFP-siRNA) for 36 h (A and E), or 56 h (B-D and F).
###end p 184
###begin p 185
(A) mRNA level of h-GAAP in HeLa cells was assessed by semi-quantitative RT-PCR (35 cycles) using h-GAAP- or actin-specific primers, respectively. -RT indicates negative control.
###end p 185
###begin p 186
(B) HeLa cell morphology was recorded using a Zeiss Axiovert 200M Live Imaging System with an AxioCam HRc CCD. Images shown are representative of at least three independent experiments.
###end p 186
###begin p 187
###xml 371 380 371 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat-0030017-sg002">Figure S2</xref>
###xml 386 387 386 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 399 400 399 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
(C) HeLa cells were loaded with the fluorescent dye TMRE and loss of the inner mitochondrial membrane potential was assessed by TMRE fluorescence two-color flow cytometry. The graph shows the percentage of cells with decreased TMRE uptake compared to mock-transfected cells. Data are mean percentages from at least three independent experiments (one of which is shown in Figure S2). *, p < 0.05; ** p < 0.005.
###end p 187
###begin p 188
(D) HeLa cells were treated with GFP-siRNA or h-GAAP siRNA1 or were mock-treated and assessed for cleavage of PARP by immunoblotting.
###end p 188
###begin p 189
(E and F) h-GAAP protein expression in U2OS-h-GAAP cells was assessed by immunofluorescence (E) or immunoblotting (F) using an alpha-HA mAb. In (E), the upper row of panels show the fluorescent images, and the bottom row shows a merged image of the top panels and an image of the same cells taken by differential interference contrast microscopy. Data are representative of three independent experiments. Scale bars, 20 mum.
###end p 189
###begin title 190
h-GAAP Decreases Cell Susceptibility to Intrinsic Apoptosis Pathways
###end title 190
###begin p 191
(A) Transient assay of Bax-induced apoptosis. Saos-2 cells were transfected with different plasmids as indicated, and representative flow cytometry profiles of CD20-positive cells are shown. The bar graph represents the percentage of sub-G1 cells (labeled M1 in the left panel). Data are mean percentages from at least two independent experiments. Protein expression was detected by immunoblotting using alpha-Bax or alpha-HA antibodies, respectively.
###end p 191
###begin p 192
###xml 162 163 159 160 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
(B-D) U2OS-neo, U2OS-v-GAAP, or U2OS-h-GAAP cells were mock-treated or treated with 3 muM staurosporine for 6 h (B), 10 mug/ml cisplatin for 24 h (C), or 10 muM C2-ceramide for 36 h (D), and apoptosis was assessed as above. The graphs show the relative percentage of apoptosis induced by staurosporine (B) or cisplatin (C). Data are mean percentages (+/- 1 standard deviation [SD]) from at least two independent experiments done in triplicate.
###end p 192
###begin p 193
###xml 31 32 31 32 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 83 91 83 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030017-g003">Figure 3</xref>
###xml 153 154 153 154 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
(D) After 24 h treatment with C2-ceramide, the cell morphology was recorded as for Figure 3B. The graphs show the percentage of sub-G1 cells induced by C2-ceramide. Data are mean percentages (+/- 1 SD) from at least two independent experiments done in triplicate. Statistically significant differences are shown.
###end p 193
###begin title 194
h-GAAP Decreases Cell Susceptibility to Extrinsic Apoptosis Pathways
###end title 194
###begin p 195
(A) U2OS-neo, U2OS-v-GAAP, or U2OS-h-GAAP cells were treated with 10 mug/ml of CHX alone or together with 500 ng/ml of anti-Fas Ab or 10 ng/ml of TNF-alpha. The bar graph represents the percentage of apoptotic cells (+/- 1 SD) after 24 h.
###end p 195
###begin p 196
(B) Relative inhibition of Fas and TNF-alpha-induced apoptosis in U2OS-neo (designated as 100%), U2OS-v-GAAP, and U2OS-h-GAAP cells. Data are mean percentages (+/- 1 SD) from at least three independent experiments. Statistically significant differences are shown.
###end p 196
###begin p 197
(C and D) After 2, 4, or 6 h incubation with TNF-alpha and cycloheximide, proteolytic cleavage of caspase-8 into p43/p41 and p18 fragments (C) and PARP (D) were assessed by immunoblotting.
###end p 197
###begin title 198
v-GAAP Complements for Loss of h-GAAP
###end title 198
###begin p 199
(A) U2OS-v-GAAP or U2OS-h-GAAP cells were transfected with siRNA oligonucleotides directed against h-GAAP (siRNAs 1-3) or v-GAAP (siRNA1) for 36 h. v-GAAP and h-GAAP expression was assessed by immunofluorescence using an alpha-HA mAb, followed by secondary Ab conjugated to FITC. The upper and third rows of panels show the fluorescent images, and the second and bottom rows show merged images of the fluorescent panel (immediately above) and an image of the same cells taken by differential interference contrast microscopy. Images shown are representative for at least three independent experiments. Scale bars, 20 mum.
###end p 199
###begin p 200
###xml 121 129 121 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030017-g004">Figure 4</xref>
(B) Cell morphology of U2OS-h-GAAP or U2OS-v-GAAP cells 56 h after transfection with GAAP siRNAs 1-3 was assessed as for Figure 4B.
###end p 200
###begin title 201
v-GAAP Is an Immunomodulator
###end title 201
###begin p 202
###xml 102 103 102 103 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 22 26 <span type="species:ncbi:10090">mice</span>
Groups of four BALB/c mice aged between 6 and 8 wk were mock-infected with PBS (*) or infected with 107 pfu of v-GAAP WT (diamond), v-DeltaGAAP (), or v-GAAP Rev (black triangle).
###end p 202
###begin p 203
###xml 4 8 <span type="species:ncbi:10090">Mice</span>
(A) Mice were weighed daily, and results are the mean percentage weight change of each group +/- standard error of the mean (SEM) compared with the weight on the day of infection.
###end p 203
###begin p 204
###xml 95 97 95 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030017-b027">27</xref>
###xml 140 141 138 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 184 185 182 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 254 255 252 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 266 270 <span type="species:ncbi:10090">mice</span>
###xml 345 349 <span type="species:ncbi:10090">mice</span>
(B) Animals from (A) were monitored daily for signs of illness, which was scored as described [27]. Data are expressed as the mean +/- SEM. p-Values were determined by using Student's t-test and indicate mean weight loss (A) or mean signs of illness. *, p-values of mice infected with v-DeltaGAAP that were significantly different from those of mice infected with v-GAAP WT and v-GAAP Rev (B).
###end p 204
###begin p 205
###xml 38 39 38 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 350 351 340 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 4 8 <span type="species:ncbi:10090">Mice</span>
###xml 216 221 <span type="species:ncbi:10090">mouse</span>
###xml 470 474 <span type="species:ncbi:10090">mice</span>
(C) Mice infected intranasally with 107 pfu of v-GAAP WT, v-DeltaGAAP, or v-GAAP Rev were sacrificed at various days p.i. as indicated. BAL cells were recovered and counted. Columns represent the mean cell yield per mouse +/- SEM. Those marked with an asterisk indicate mean cell numbers recovered with v-DeltaGAAP that were significantly different (p < 0.05) from those recovered from v-GAAP WT and v-GAAP Rev (three independent experiments with groups of four to five mice).
###end p 205
###begin p 206
currency Current address: Ludwig Institute for Cancer Research, University College London, London, United Kingdom
###end p 206
###begin p 207
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Author contributions.</bold>
Author contributions. CG, MH, FJMvK, and GLS conceived and designed the experiments. CG, DB, and MH performed the experiments. CG, MH, XL, FJMvK, and GLS analyzed the data. DB and XL contributed reagents/materials/analysis tools. CG, FJMvK, and GLS wrote the paper.
###end p 207
###begin p 208
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding.</bold>
Funding. The work was supported by grants from the Wellcome Trust. GLS is a Wellcome Trust Principal Research Fellow. FJMvK is supported by grants from the Netherlands Organization for Scientific Research (NWO-VIDI-917.46.305).
###end p 208
###begin p 209
###xml 0 20 0 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing interests.</bold>
Competing interests. The authors have declared that no competing interests exist.
###end p 209

